Goldman Sachs’s Innoviva INVA Stock Holding History

Goldman Sachs’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-181,000	Closed	-$2.63M	–	5268
2019 Q2	$2.63M	Buy	181,000 +1,000	+0.6%	+$14.2K	﹤0.01%	3353
2019 Q1	$2.52M	Buy	+180,000	New	+$2.91M	﹤0.01%	3465
2017 Q3	–	Sell	-5,900	Closed	-$76K	–	6751
2017 Q2	$76K	Buy	+5,900	New	+$74K	﹤0.01%	6227
2017 Q1	–	Sell	-900,000	Closed	-$9.63M	–	6879
2016 Q4	$9.63M	Sell	900,000 -450,000	-33%	-$4.72M	﹤0.01%	2499
2016 Q3	$14.8M	Buy	+1,350,000	New	+$15.8M	﹤0.01%	2132
2015 Q2	–	Sell	-28,200	Closed	-$443K	–	7337
2015 Q1	$443K	Buy	+28,200	New	+$427K	﹤0.01%	5261
2014 Q1	–	Sell	-230,330	Closed	-$6.62M	–	6838
2013 Q4	$6.62M	Buy	+230,330	New	+$6.74M	﹤0.01%	2770

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's INVA Position: Q1 2026 in Review

Goldman Sachs increased its Innoviva (INVA) stake by 42% in Q1 2026, buying an estimated $10.2M and bringing the position to 1,593,383 shares worth $37.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1821.

Goldman Sachs first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

Goldman Sachs held 1,593,383 shares of Innoviva worth $37.1M as of Q1 2026.
Goldman Sachs bought 471,412 Innoviva shares in Q1 2026, an estimated $10.2M.
Innoviva made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1821 holding.
Goldman Sachs first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.